These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9214631)
1. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. Schouten GJ; Vertegaal AC; Whiteside ST; Israël A; Toebes M; Dorsman JC; van der Eb AJ; Zantema A EMBO J; 1997 Jun; 16(11):3133-44. PubMed ID: 9214631 [TBL] [Abstract][Full Text] [Related]
2. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex. Heilker R; Freuler F; Pulfer R; Di Padova F; Eder J Eur J Biochem; 1999 Jan; 259(1-2):253-61. PubMed ID: 9914500 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells. Vertegaal AC; Kuiperij HB; Yamaoka S; Courtois G; van der Eb AJ; Zantema A Cell Signal; 2000 Dec; 12(11-12):759-68. PubMed ID: 11152962 [TBL] [Abstract][Full Text] [Related]
4. The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase. Ten RM; McKinstry MJ; Trushin SA; Asin S; Paya CV J Immunol; 1999 Oct; 163(7):3851-7. PubMed ID: 10490984 [TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells. Berry DM; Clark CS; Meckling-Gill KA Exp Cell Res; 2002 Jan; 272(2):176-84. PubMed ID: 11777342 [TBL] [Abstract][Full Text] [Related]
6. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. Ghoda L; Lin X; Greene WC J Biol Chem; 1997 Aug; 272(34):21281-8. PubMed ID: 9261139 [TBL] [Abstract][Full Text] [Related]
7. Characterization of IkappaB kinases. IkappaB-alpha is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. Janosch P; Schellerer M; Seitz T; Reim P; Eulitz M; Brielmeier M; Kölch W; Sedivy JM; Mischak H J Biol Chem; 1996 Jun; 271(23):13868-74. PubMed ID: 8662925 [TBL] [Abstract][Full Text] [Related]
8. Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of IkappaB kinase. Hughes K; Edin S; Antonsson A; Grundström T J Biol Chem; 2001 Sep; 276(38):36008-13. PubMed ID: 11470799 [TBL] [Abstract][Full Text] [Related]
9. DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties. Liu L; Kwak YT; Bex F; García-Martínez LF; Li XH; Meek K; Lane WS; Gaynor RB Mol Cell Biol; 1998 Jul; 18(7):4221-34. PubMed ID: 9632806 [TBL] [Abstract][Full Text] [Related]
11. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Yin MJ; Christerson LB; Yamamoto Y; Kwak YT; Xu S; Mercurio F; Barbosa M; Cobb MH; Gaynor RB Cell; 1998 May; 93(5):875-84. PubMed ID: 9630230 [TBL] [Abstract][Full Text] [Related]
12. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784 [TBL] [Abstract][Full Text] [Related]
13. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080 [TBL] [Abstract][Full Text] [Related]
14. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription. Devalaraja MN; Wang DZ; Ballard DW; Richmond A Cancer Res; 1999 Mar; 59(6):1372-7. PubMed ID: 10096573 [TBL] [Abstract][Full Text] [Related]
15. Regulation and function of IKK and IKK-related kinases. Häcker H; Karin M Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224 [TBL] [Abstract][Full Text] [Related]
16. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. Manna SK; Aggarwal BB J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347 [TBL] [Abstract][Full Text] [Related]
17. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest. Sutherland CL; Krebs DL; Gold MR J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655 [TBL] [Abstract][Full Text] [Related]
19. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. Awane M; Andres PG; Li DJ; Reinecker HC J Immunol; 1999 May; 162(9):5337-44. PubMed ID: 10228009 [TBL] [Abstract][Full Text] [Related]
20. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Whiteside ST; Ernst MK; LeBail O; Laurent-Winter C; Rice N; Israël A Mol Cell Biol; 1995 Oct; 15(10):5339-45. PubMed ID: 7565683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]